世界の薬力学的バイオマーカー試験市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Pharmacodynamic Biomarker Testing Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4704 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、薬力学的バイオマーカー試験の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（LC-MS、MS）、用途別市場規模（病院、診断センター、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・薬力学的バイオマーカー試験の市場動向 ・企業の競争状況、市場シェア ・薬力学的バイオマーカー試験の種類別市場規模と予測2016-2027（LC-MS、MS） ・薬力学的バイオマーカー試験の用途別市場規模と予測2016-2027（病院、診断センター、その他） ・薬力学的バイオマーカー試験の北米市場規模2016-2027（アメリカ、カナダ） ・薬力学的バイオマーカー試験の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・薬力学的バイオマーカー試験のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・薬力学的バイオマーカー試験の中南米市場規模2016-2027（メキシコ、ブラジル） ・薬力学的バイオマーカー試験の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Almac、ACM Global Laboratories、Charles River、Agilent、Sygnature Discovery、Myriad RBM、AstraZeneca、BioAgilytix Labs、Merck） ・結論

Market Analysis and Insights: Global Pharmacodynamic Biomarker Testing Market
The global Pharmacodynamic Biomarker Testing market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Pharmacodynamic Biomarker Testing market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Pharmacodynamic Biomarker Testing market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Pharmacodynamic Biomarker Testing market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Pharmacodynamic Biomarker Testing market.

Global Pharmacodynamic Biomarker Testing Scope and Market Size
Pharmacodynamic Biomarker Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Pharmacodynamic Biomarker Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
LC-MS
MS

Segment by Application
Hospital
Diagnostic Center
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Almac
ACM Global Laboratories
Charles River
Agilent
Sygnature Discovery
Myriad RBM
AstraZeneca
BioAgilytix Labs
Merck

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmacodynamic Biomarker Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 LC-MS
1.2.3 MS
1.3 Market by Application
1.3.1 Global Pharmacodynamic Biomarker Testing Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Diagnostic Center
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Pharmacodynamic Biomarker Testing Market Perspective (2016-2027)
2.2 Pharmacodynamic Biomarker Testing Growth Trends by Regions
2.2.1 Pharmacodynamic Biomarker Testing Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Pharmacodynamic Biomarker Testing Historic Market Share by Regions (2016-2021)
2.2.3 Pharmacodynamic Biomarker Testing Forecasted Market Size by Regions (2022-2027)
2.3 Pharmacodynamic Biomarker Testing Industry Dynamic
2.3.1 Pharmacodynamic Biomarker Testing Market Trends
2.3.2 Pharmacodynamic Biomarker Testing Market Drivers
2.3.3 Pharmacodynamic Biomarker Testing Market Challenges
2.3.4 Pharmacodynamic Biomarker Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Pharmacodynamic Biomarker Testing Players by Revenue
3.1.1 Global Top Pharmacodynamic Biomarker Testing Players by Revenue (2016-2021)
3.1.2 Global Pharmacodynamic Biomarker Testing Revenue Market Share by Players (2016-2021)
3.2 Global Pharmacodynamic Biomarker Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Pharmacodynamic Biomarker Testing Revenue
3.4 Global Pharmacodynamic Biomarker Testing Market Concentration Ratio
3.4.1 Global Pharmacodynamic Biomarker Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmacodynamic Biomarker Testing Revenue in 2020
3.5 Pharmacodynamic Biomarker Testing Key Players Head office and Area Served
3.6 Key Players Pharmacodynamic Biomarker Testing Product Solution and Service
3.7 Date of Enter into Pharmacodynamic Biomarker Testing Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Pharmacodynamic Biomarker Testing Breakdown Data by Type
4.1 Global Pharmacodynamic Biomarker Testing Historic Market Size by Type (2016-2021)
4.2 Global Pharmacodynamic Biomarker Testing Forecasted Market Size by Type (2022-2027)

5 Pharmacodynamic Biomarker Testing Breakdown Data by Application
5.1 Global Pharmacodynamic Biomarker Testing Historic Market Size by Application (2016-2021)
5.2 Global Pharmacodynamic Biomarker Testing Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Pharmacodynamic Biomarker Testing Market Size (2016-2027)
6.2 North America Pharmacodynamic Biomarker Testing Market Size by Type
6.2.1 North America Pharmacodynamic Biomarker Testing Market Size by Type (2016-2021)
6.2.2 North America Pharmacodynamic Biomarker Testing Market Size by Type (2022-2027)
6.2.3 North America Pharmacodynamic Biomarker Testing Market Size by Type (2016-2027)
6.3 North America Pharmacodynamic Biomarker Testing Market Size by Application
6.3.1 North America Pharmacodynamic Biomarker Testing Market Size by Application (2016-2021)
6.3.2 North America Pharmacodynamic Biomarker Testing Market Size by Application (2022-2027)
6.3.3 North America Pharmacodynamic Biomarker Testing Market Size by Application (2016-2027)
6.4 North America Pharmacodynamic Biomarker Testing Market Size by Country
6.4.1 North America Pharmacodynamic Biomarker Testing Market Size by Country (2016-2021)
6.4.2 North America Pharmacodynamic Biomarker Testing Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Pharmacodynamic Biomarker Testing Market Size (2016-2027)
7.2 Europe Pharmacodynamic Biomarker Testing Market Size by Type
7.2.1 Europe Pharmacodynamic Biomarker Testing Market Size by Type (2016-2021)
7.2.2 Europe Pharmacodynamic Biomarker Testing Market Size by Type (2022-2027)
7.2.3 Europe Pharmacodynamic Biomarker Testing Market Size by Type (2016-2027)
7.3 Europe Pharmacodynamic Biomarker Testing Market Size by Application
7.3.1 Europe Pharmacodynamic Biomarker Testing Market Size by Application (2016-2021)
7.3.2 Europe Pharmacodynamic Biomarker Testing Market Size by Application (2022-2027)
7.3.3 Europe Pharmacodynamic Biomarker Testing Market Size by Application (2016-2027)
7.4 Europe Pharmacodynamic Biomarker Testing Market Size by Country
7.4.1 Europe Pharmacodynamic Biomarker Testing Market Size by Country (2016-2021)
7.4.2 Europe Pharmacodynamic Biomarker Testing Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Pharmacodynamic Biomarker Testing Market Size (2016-2027)
8.2 Asia-Pacific Pharmacodynamic Biomarker Testing Market Size by Type
8.2.1 Asia-Pacific Pharmacodynamic Biomarker Testing Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Pharmacodynamic Biomarker Testing Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Pharmacodynamic Biomarker Testing Market Size by Type (2016-2027)
8.3 Asia-Pacific Pharmacodynamic Biomarker Testing Market Size by Application
8.3.1 Asia-Pacific Pharmacodynamic Biomarker Testing Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Pharmacodynamic Biomarker Testing Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Pharmacodynamic Biomarker Testing Market Size by Application (2016-2027)
8.4 Asia-Pacific Pharmacodynamic Biomarker Testing Market Size by Region
8.4.1 Asia-Pacific Pharmacodynamic Biomarker Testing Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Pharmacodynamic Biomarker Testing Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Pharmacodynamic Biomarker Testing Market Size (2016-2027)
9.2 Latin America Pharmacodynamic Biomarker Testing Market Size by Type
9.2.1 Latin America Pharmacodynamic Biomarker Testing Market Size by Type (2016-2021)
9.2.2 Latin America Pharmacodynamic Biomarker Testing Market Size by Type (2022-2027)
9.2.3 Latin America Pharmacodynamic Biomarker Testing Market Size by Type (2016-2027)
9.3 Latin America Pharmacodynamic Biomarker Testing Market Size by Application
9.3.1 Latin America Pharmacodynamic Biomarker Testing Market Size by Application (2016-2021)
9.3.2 Latin America Pharmacodynamic Biomarker Testing Market Size by Application (2022-2027)
9.3.3 Latin America Pharmacodynamic Biomarker Testing Market Size by Application (2016-2027)
9.4 Latin America Pharmacodynamic Biomarker Testing Market Size by Country
9.4.1 Latin America Pharmacodynamic Biomarker Testing Market Size by Country (2016-2021)
9.4.2 Latin America Pharmacodynamic Biomarker Testing Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Pharmacodynamic Biomarker Testing Market Size (2016-2027)
10.2 Middle East & Africa Pharmacodynamic Biomarker Testing Market Size by Type
10.2.1 Middle East & Africa Pharmacodynamic Biomarker Testing Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Pharmacodynamic Biomarker Testing Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Pharmacodynamic Biomarker Testing Market Size by Type (2016-2027)
10.3 Middle East & Africa Pharmacodynamic Biomarker Testing Market Size by Application
10.3.1 Middle East & Africa Pharmacodynamic Biomarker Testing Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Pharmacodynamic Biomarker Testing Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Pharmacodynamic Biomarker Testing Market Size by Application (2016-2027)
10.4 Middle East & Africa Pharmacodynamic Biomarker Testing Market Size by Country
10.4.1 Middle East & Africa Pharmacodynamic Biomarker Testing Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Pharmacodynamic Biomarker Testing Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Almac
11.1.1 Almac Company Details
11.1.2 Almac Business Overview
11.1.3 Almac Pharmacodynamic Biomarker Testing Introduction
11.1.4 Almac Revenue in Pharmacodynamic Biomarker Testing Business (2016-2021)
11.1.5 Almac Recent Development
11.2 ACM Global Laboratories
11.2.1 ACM Global Laboratories Company Details
11.2.2 ACM Global Laboratories Business Overview
11.2.3 ACM Global Laboratories Pharmacodynamic Biomarker Testing Introduction
11.2.4 ACM Global Laboratories Revenue in Pharmacodynamic Biomarker Testing Business (2016-2021)
11.2.5 ACM Global Laboratories Recent Development
11.3 Charles River
11.3.1 Charles River Company Details
11.3.2 Charles River Business Overview
11.3.3 Charles River Pharmacodynamic Biomarker Testing Introduction
11.3.4 Charles River Revenue in Pharmacodynamic Biomarker Testing Business (2016-2021)
11.3.5 Charles River Recent Development
11.4 Agilent
11.4.1 Agilent Company Details
11.4.2 Agilent Business Overview
11.4.3 Agilent Pharmacodynamic Biomarker Testing Introduction
11.4.4 Agilent Revenue in Pharmacodynamic Biomarker Testing Business (2016-2021)
11.4.5 Agilent Recent Development
11.5 Sygnature Discovery
11.5.1 Sygnature Discovery Company Details
11.5.2 Sygnature Discovery Business Overview
11.5.3 Sygnature Discovery Pharmacodynamic Biomarker Testing Introduction
11.5.4 Sygnature Discovery Revenue in Pharmacodynamic Biomarker Testing Business (2016-2021)
11.5.5 Sygnature Discovery Recent Development
11.6 Myriad RBM
11.6.1 Myriad RBM Company Details
11.6.2 Myriad RBM Business Overview
11.6.3 Myriad RBM Pharmacodynamic Biomarker Testing Introduction
11.6.4 Myriad RBM Revenue in Pharmacodynamic Biomarker Testing Business (2016-2021)
11.6.5 Myriad RBM Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Pharmacodynamic Biomarker Testing Introduction
11.7.4 AstraZeneca Revenue in Pharmacodynamic Biomarker Testing Business (2016-2021)
11.7.5 AstraZeneca Recent Development
11.8 BioAgilytix Labs
11.8.1 BioAgilytix Labs Company Details
11.8.2 BioAgilytix Labs Business Overview
11.8.3 BioAgilytix Labs Pharmacodynamic Biomarker Testing Introduction
11.8.4 BioAgilytix Labs Revenue in Pharmacodynamic Biomarker Testing Business (2016-2021)
11.8.5 BioAgilytix Labs Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Pharmacodynamic Biomarker Testing Introduction
11.9.4 Merck Revenue in Pharmacodynamic Biomarker Testing Business (2016-2021)
11.9.5 Merck Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Pharmacodynamic Biomarker Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of LC-MS
Table 3. Key Players of MS
Table 4. Global Pharmacodynamic Biomarker Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Pharmacodynamic Biomarker Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Pharmacodynamic Biomarker Testing Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Pharmacodynamic Biomarker Testing Market Share by Regions (2016-2021)
Table 8. Global Pharmacodynamic Biomarker Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Pharmacodynamic Biomarker Testing Market Share by Regions (2022-2027)
Table 10. Pharmacodynamic Biomarker Testing Market Trends
Table 11. Pharmacodynamic Biomarker Testing Market Drivers
Table 12. Pharmacodynamic Biomarker Testing Market Challenges
Table 13. Pharmacodynamic Biomarker Testing Market Restraints
Table 14. Global Pharmacodynamic Biomarker Testing Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Pharmacodynamic Biomarker Testing Market Share by Players (2016-2021)
Table 16. Global Top Pharmacodynamic Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacodynamic Biomarker Testing as of 2020)
Table 17. Ranking of Global Top Pharmacodynamic Biomarker Testing Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Pharmacodynamic Biomarker Testing Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Pharmacodynamic Biomarker Testing Product Solution and Service
Table 21. Date of Enter into Pharmacodynamic Biomarker Testing Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pharmacodynamic Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Pharmacodynamic Biomarker Testing Revenue Market Share by Type (2016-2021)
Table 25. Global Pharmacodynamic Biomarker Testing Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Pharmacodynamic Biomarker Testing Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Pharmacodynamic Biomarker Testing Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Pharmacodynamic Biomarker Testing Revenue Market Share by Application (2016-2021)
Table 29. Global Pharmacodynamic Biomarker Testing Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Pharmacodynamic Biomarker Testing Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Pharmacodynamic Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Pharmacodynamic Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Pharmacodynamic Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Pharmacodynamic Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Pharmacodynamic Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Pharmacodynamic Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Pharmacodynamic Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Pharmacodynamic Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Pharmacodynamic Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Pharmacodynamic Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Pharmacodynamic Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Pharmacodynamic Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Pharmacodynamic Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Pharmacodynamic Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Pharmacodynamic Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Pharmacodynamic Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Pharmacodynamic Biomarker Testing Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Pharmacodynamic Biomarker Testing Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Pharmacodynamic Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Pharmacodynamic Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Pharmacodynamic Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Pharmacodynamic Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Pharmacodynamic Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Pharmacodynamic Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Pharmacodynamic Biomarker Testing Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Pharmacodynamic Biomarker Testing Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Pharmacodynamic Biomarker Testing Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Pharmacodynamic Biomarker Testing Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Pharmacodynamic Biomarker Testing Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Pharmacodynamic Biomarker Testing Market Size by Country (2022-2027) & (US$ Million)
Table 61. Almac Company Details
Table 62. Almac Business Overview
Table 63. Almac Pharmacodynamic Biomarker Testing Product
Table 64. Almac Revenue in Pharmacodynamic Biomarker Testing Business (2016-2021) & (US$ Million)
Table 65. Almac Recent Development
Table 66. ACM Global Laboratories Company Details
Table 67. ACM Global Laboratories Business Overview
Table 68. ACM Global Laboratories Pharmacodynamic Biomarker Testing Product
Table 69. ACM Global Laboratories Revenue in Pharmacodynamic Biomarker Testing Business (2016-2021) & (US$ Million)
Table 70. ACM Global Laboratories Recent Development
Table 71. Charles River Company Details
Table 72. Charles River Business Overview
Table 73. Charles River Pharmacodynamic Biomarker Testing Product
Table 74. Charles River Revenue in Pharmacodynamic Biomarker Testing Business (2016-2021) & (US$ Million)
Table 75. Charles River Recent Development
Table 76. Agilent Company Details
Table 77. Agilent Business Overview
Table 78. Agilent Pharmacodynamic Biomarker Testing Product
Table 79. Agilent Revenue in Pharmacodynamic Biomarker Testing Business (2016-2021) & (US$ Million)
Table 80. Agilent Recent Development
Table 81. Sygnature Discovery Company Details
Table 82. Sygnature Discovery Business Overview
Table 83. Sygnature Discovery Pharmacodynamic Biomarker Testing Product
Table 84. Sygnature Discovery Revenue in Pharmacodynamic Biomarker Testing Business (2016-2021) & (US$ Million)
Table 85. Sygnature Discovery Recent Development
Table 86. Myriad RBM Company Details
Table 87. Myriad RBM Business Overview
Table 88. Myriad RBM Pharmacodynamic Biomarker Testing Product
Table 89. Myriad RBM Revenue in Pharmacodynamic Biomarker Testing Business (2016-2021) & (US$ Million)
Table 90. Myriad RBM Recent Development
Table 91. AstraZeneca Company Details
Table 92. AstraZeneca Business Overview
Table 93. AstraZeneca Pharmacodynamic Biomarker Testing Product
Table 94. AstraZeneca Revenue in Pharmacodynamic Biomarker Testing Business (2016-2021) & (US$ Million)
Table 95. AstraZeneca Recent Development
Table 96. BioAgilytix Labs Company Details
Table 97. BioAgilytix Labs Business Overview
Table 98. BioAgilytix Labs Revenue in Pharmacodynamic Biomarker Testing Business (2016-2021) & (US$ Million)
Table 99. BioAgilytix Labs Recent Development
Table 100. Merck Company Details
Table 101. Merck Business Overview
Table 102. Merck Pharmacodynamic Biomarker Testing Product
Table 103. Merck Revenue in Pharmacodynamic Biomarker Testing Business (2016-2021) & (US$ Million)
Table 104. Merck Recent Development
Table 105. Research Programs/Design for This Report
Table 106. Key Data Information from Secondary Sources
Table 107. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pharmacodynamic Biomarker Testing Market Share by Type: 2020 VS 2027
Figure 2. LC-MS Features
Figure 3. MS Features
Figure 4. Global Pharmacodynamic Biomarker Testing Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Diagnostic Center Case Studies
Figure 7. Others Case Studies
Figure 8. Pharmacodynamic Biomarker Testing Report Years Considered
Figure 9. Global Pharmacodynamic Biomarker Testing Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Pharmacodynamic Biomarker Testing Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Pharmacodynamic Biomarker Testing Market Share by Regions: 2020 VS 2027
Figure 12. Global Pharmacodynamic Biomarker Testing Market Share by Regions (2022-2027)
Figure 13. Global Pharmacodynamic Biomarker Testing Market Share by Players in 2020
Figure 14. Global Top Pharmacodynamic Biomarker Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Pharmacodynamic Biomarker Testing as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Pharmacodynamic Biomarker Testing Revenue in 2020
Figure 16. Global Pharmacodynamic Biomarker Testing Revenue Market Share by Type (2016-2021)
Figure 17. Global Pharmacodynamic Biomarker Testing Revenue Market Share by Type (2022-2027)
Figure 18. North America Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Pharmacodynamic Biomarker Testing Market Share by Type (2016-2027)
Figure 20. North America Pharmacodynamic Biomarker Testing Market Share by Application (2016-2027)
Figure 21. North America Pharmacodynamic Biomarker Testing Market Share by Country (2016-2027)
Figure 22. United States Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Pharmacodynamic Biomarker Testing Market Share by Type (2016-2027)
Figure 26. Europe Pharmacodynamic Biomarker Testing Market Share by Application (2016-2027)
Figure 27. Europe Pharmacodynamic Biomarker Testing Market Share by Country (2016-2027)
Figure 28. Germany Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Pharmacodynamic Biomarker Testing Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Pharmacodynamic Biomarker Testing Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Pharmacodynamic Biomarker Testing Market Share by Region (2016-2027)
Figure 38. China Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Pharmacodynamic Biomarker Testing Market Share by Type (2016-2027)
Figure 46. Latin America Pharmacodynamic Biomarker Testing Market Share by Application (2016-2027)
Figure 47. Latin America Pharmacodynamic Biomarker Testing Market Share by Country (2016-2027)
Figure 48. Mexico Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Pharmacodynamic Biomarker Testing Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Pharmacodynamic Biomarker Testing Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Pharmacodynamic Biomarker Testing Market Share by Country (2016-2027)
Figure 54. Turkey Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Pharmacodynamic Biomarker Testing Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Almac Revenue Growth Rate in Pharmacodynamic Biomarker Testing Business (2016-2021)
Figure 58. ACM Global Laboratories Revenue Growth Rate in Pharmacodynamic Biomarker Testing Business (2016-2021)
Figure 59. Charles River Revenue Growth Rate in Pharmacodynamic Biomarker Testing Business (2016-2021)
Figure 60. Agilent Revenue Growth Rate in Pharmacodynamic Biomarker Testing Business (2016-2021)
Figure 61. Sygnature Discovery Revenue Growth Rate in Pharmacodynamic Biomarker Testing Business (2016-2021)
Figure 62. Myriad RBM Revenue Growth Rate in Pharmacodynamic Biomarker Testing Business (2016-2021)
Figure 63. AstraZeneca Revenue Growth Rate in Pharmacodynamic Biomarker Testing Business (2016-2021)
Figure 64. BioAgilytix Labs Revenue Growth Rate in Pharmacodynamic Biomarker Testing Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Pharmacodynamic Biomarker Testing Business (2016-2021)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed

---